On Invalid Date, Iovance Biotherapeutics (NASDAQ: IOVA) reported Q4 2023 earnings per share (EPS) of -$0.45, up 29.69% year over year. Total Iovance Biotherapeutics earnings for the quarter were -$116.38 million. In the same quarter last year, Iovance Biotherapeutics's earnings per share (EPS) was -$0.64.
As of Q2 2024, Iovance Biotherapeutics's earnings has grown year over year. Iovance Biotherapeutics's earnings in the past year totalled -$444.04 million.
What is IOVA's earnings date?
Iovance Biotherapeutics's earnings date is Invalid Date. Add IOVA to your watchlist to be reminded of IOVA's next earnings announcement.
What was IOVA's revenue last quarter?
On Invalid Date, Iovance Biotherapeutics (NASDAQ: IOVA) reported Q4 2023 revenue of $482.00 thousand up Infinity% year over year. In the same quarter last year, Iovance Biotherapeutics's revenue was $0.00.
What was IOVA's revenue growth in the past year?
As of Q2 2024, Iovance Biotherapeutics's revenue has grown null year over year. Iovance Biotherapeutics's revenue in the past year totalled $1.19 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.